Lifecore Biomedical Stock

Lifecore Biomedical Net Margin

The Net Profit Margin of Lifecore Biomedical (LFCR) as of Aug 8, 2026 is -23.78 %. In the previous year, Net Profit Margin was -30.04 % — a change of -20.84% (higher).

Net Margin

-23.78 %

YoY

-20.84%

Last updated:

Net Profit Margin of Lifecore Biomedical is 2026 -23.78 % . Net Profit Margin of Lifecore Biomedical was 2025 -30.04 % . It decreases by -20.84% higher compared to the previous year.

Lifecore Biomedical's net margin stands at -23.8%, up from -52.4% several years earlier.

Access this data via the Eulerpool API
Get Free API Key

Lifecore Biomedical Stock analysis

What does Lifecore Biomedical do? Landec Corp is a US-American company specialized in the development, manufacturing, and marketing of innovative products in the Agribusiness and Biotechnology sectors. It was founded in 1986 as a spin-off from the engineering faculty of Stanford University. The company follows a unique business model based on the integration of advanced technologies and biological processes. This aims to achieve sustainable agriculture that is both mindful of natural resources and achieves high yields. One of Landec's main divisions is the Fresh-Cut Products segment, where the company produces a variety of high-quality salads, vegetable, and fruit snacks that are distributed under the brand Eat Smart®. These products are known for their freshness, taste, and healthy nutritional values, and have gained high recognition in the USA. Another important business division of Landec is the Apio Packaging segment, specialized in the manufacturing and marketing of innovative packaging solutions for fresh fruits and vegetables. The packaging, distributed under the brand BreatheWay®, is equipped with a unique technology that regulates gas exchange within the package and extends the shelf life of the contents. In addition to these core segments, Landec is also active in the field of Biotechnology. Here, the company develops innovative products and technologies for use in human healthcare as well as the agricultural industry. An example of this is Apio's recently introduced whole plant juice called GreenWise™. Landec Corp is known for its innovation capabilities and its ability to develop new products and technologies. Throughout its history, the company has acquired a number of patents and awards and constantly strives to improve and advance its products. Overall, Landec Corp is a company that focuses on sustainability, innovation, and quality. With its unique business model and wide range of products and services, the company is well-positioned to continue growing and expanding its leadership position in the agriculture and biotechnology industry. Lifecore Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifecore Biomedical stock

Net Profit Margin of Lifecore Biomedical is -23.78 % in 2026.

Net Profit Margin of Lifecore Biomedical changed from -30.04 % to -23.78 %, representing a -20.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Lifecore Biomedical since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Lifecore Biomedical with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API
Get Free API Key

Margins — Lifecore Biomedical

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Lifecore Biomedical